• Return to Headlines

Inc Research H-A has the Highest EBITDA Growth in the Life Sciences Tools & Services Industry (INCR, NEO, PRAH, BIO, PKI)

By Shiri Gupta

Below are the three companies in the Life Sciences Tools & Services industry with the highest EBITDA Growth (next year estimate vs. LTM). EBITDA Growth can be valuable in predicting future cash flow generation and earnings power.

Inc Research H-A ranks highest with a EBITDA growth of 266.9%. Following is Neogenomics Inc with a EBITDA growth of 84.3%. Pra Health Scien ranks third highest with a EBITDA growth of 75.2%.

Bio-Rad Labs-A follows with a EBITDA growth of 54.5%, and Perkinelmer Inc rounds out the top five with a EBITDA growth of 47.7%.

SmarTrend recommended that subscribers consider buying shares of Perkinelmer Inc on July 9th, 2018 as our technology indicated a new Uptrend was in progress when shares hit $75.09. Since that recommendation, shares of Perkinelmer Inc have risen 13.1%. We continue to monitor Perkinelmer Inc for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately.

Keywords: highest ebitda growth :incr inc research h-a neogenomics inc pra health scien bio-rad labs-a perkinelmer inc

Ticker(s): NEO PRAH BIO PKI